Disease Overview：Irritable Bowel Syndrome with Constipation（IBS-C）
Constipation-predominant irritable bowel syndrome (IBS-C) is a functional gastrointestinal disorder characterized by chronic abdominal discomfort or pain associated with constipation—defined by infrequent stools, straining, lumpy/hard stools, a sensation of incomplete evacuation or anorectal obstruction, and/or a feeling of abdominal bloating or distension. Unlike inflammatory or structural bowel diseases, IBS-C lacks identifiable organic pathology; diagnosis relies on Rome IV criteria after excluding red-flag conditions such as colorectal malignancy, celiac disease, or thyroid dysfunction. Pathophysiology involves complex interactions among gut motility dysregulation, visceral hypersensitivity, altered gut-brain axis signaling, and microbiota imbalances. First-line management includes dietary modification (e.g., soluble fiber supplementation, low-FODMAP diet), pharmacotherapy (laxatives, secretagogues like lubiprostone or plecanatide), and psychological interventions including cognitive behavioral therapy. Long-term symptom control often requires personalized, multidisciplinary care.
China offers distinct advantages for IBS-C management: leading digestive disease centers—such as Peking Union Medical College Hospital and Shanghai Renji Hospital—employ internationally trained gastroenterologists skilled in functional GI disorders and utilize advanced diagnostic tools including high-resolution anorectal manometry, wireless motility capsule testing, and microbiome profiling. Clinical outcomes reflect robust evidence-based protocols, with published success rates showing ≥70% sustained symptom improvement at 6 months in integrated care pathways. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising quality—generic and branded therapeutics are widely available, and outpatient consultations include comprehensive dietary counseling and follow-up coordination. As a dedicated medical tourism agency, we facilitate seamless international patient journeys: verifying hospital credentials, arranging appointments with specialists, providing itemized, transparent pricing in advance, assisting with visas and accommodation, and offering bilingual clinical coordination throughout diagnosis and treatment.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Diagnosis confirmed per Rome IV criteria; exclusion of organic disease (e.g., colorectal cancer, hypothyroidism, metabolic disorders); symptom duration ≥6 months.
- •Lifestyle & Dietary Intervention (First-line)
- Fiber supplementation (psyllium, 10 g/day × 4 weeks): $15–$25 - Daily physical activity prescription + hydration assessment: $0 (included in outpatient visit)
- •Pharmacotherapy (Tiered based on response)
- *Tier 2 (Prokinetics)*: Prucalopride (2 mg/day × 4 weeks): $140–$210 - *Tier 3 (Guanylate Cyclase-C Agonists)*: Linaclotide (145 µg/day × 4 weeks): $320–$480
- •Diagnostic & Monitoring Fees
- Thyroid function panel (TSH, FT4): $22 - Basic metabolic panel + calcium: $18 - Abdominal ultrasound (to exclude structural causes): $45
Surgical / Procedural / Interventional Options
*Eligibility criteria:* Refractory IBS-C (>12 months) with documented slow-transit constipation (colonic transit study >72 h retention), failed ≥3 pharmacologic regimens, no pelvic floor dyssynergia on anorectal manometry, and confirmed absence of megacolon or outlet obstruction.
- •Colonic Transit Study (Radiopaque Marker): $65
- •Anorectal Manometry + Balloon Expulsion Test: $95
- •Biofeedback Therapy (6 sessions): $270–$360
- •No surgical intervention is indicated for pure IBS-C — colectomy, ileostomy, or sacral nerve stimulation are contraindicated and not performed for functional IBS-C in China’s Grade 3A hospitals.
Special / Complex Condition Management
- •IBS-C with Comorbid Anxiety/Depression (PHQ-9/GAD-7 ≥10):
- Cognitive Behavioral Therapy (CBT) via GI-specialized psychologist (8 sessions): $320–$400
- •Elderly (>75 years) with Polypharmacy Risk:
- Home-based fiber/laxative titration monitoring (telehealth × 4 visits): $110
Quick Selection Guide
- •Young adult (<45), mild-moderate, budget-conscious: Start with dietary counseling + PEG → Total ~$155–$230
- •Middle-aged (45–65), severe refractory, comorbid anxiety: Prucalopride + CBT + stool testing → Total ~$550–$720
- •Elderly (>75), frail, polypharmacy: Geriatric review + telehealth titration + low-dose amitriptyline → Total ~$200–$280
- •All patients require baseline labs + ultrasound before escalation — non-negotiable safety step ($100 fixed)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Irritable Bowel Syndrome with Constipation Medical Vacation Packages
Curated transparent all-inclusive packages combining Irritable Bowel Syndrome with Constipation treatment with China top medical destinations:
